Novel assays to assess the functional capacity of the classical, the alternative and the lectin pathways of the

Y Palarasah1, C Nielsen, U Sprogøe

  • 1Department of Cancer and Inflammation, Institute of Molecular Medicine, Faculty of Health Science, University of Southern Denmark, Odense, Denmark.

Insights

Screening for complement deficiencies is crucial for diagnosing diseases like SLE. This study introduces improved enzyme-linked immunosorbent assays for accurate complement system pathway assessment, minimizing diagnostic errors.

Area of Science:

  • Immunology
  • Clinical Chemistry

Background:

  • Complement system deficiencies are linked to various diseases, including recurrent infections, systemic lupus erythematosus (SLE), and renal diseases.
  • Accurate screening for complement defects is essential for patient diagnosis and management.

Purpose of the Study:

  • To develop and validate novel, improved enzyme-linked immunosorbent assays (ELISAs) for the functional assessment of the three individual complement system pathways.
  • To enhance the diagnostic accuracy of complement deficiency testing.

Main Methods:

  • Development of novel enzyme-linked immunosorbent assays (ELISAs) for functional assessment of complement pathways.
  • Application of assays at high serum concentrations.
  • Validation of assay performance in minimizing false negative and false positive results.

Main Results:

  • The developed ELISAs provide accurate functional assessment of the three complement pathways.
  • The assays are applicable at high serum concentrations.
  • The novel method significantly minimizes both false negative and false positive results compared to existing assays, particularly for mannose-binding lectin activity.

Conclusions:

  • The improved ELISAs represent novel diagnostic protocols for patients with suspected immunodeficiencies related to the complement system.
  • These assays offer enhanced accuracy and reliability in diagnosing complement deficiencies.